Stocks Health care OTLK
NASDAQ · Health careOutlook Therapeutics, Inc. (OTLK)
It posted a net loss of $61.1M. At June 30, 2026 it held $11.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 18, 2026.
What Outlook Therapeutics, Inc. does
Outlook Therapeutics, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker OTLK.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.4M | -$62.4M | -$1.79 | n/a |
| 2024 | n/a | -$75.4M | -$4.06 | n/a |
| 2023 | n/a | -$59M | -$4.72 | n/a |
| 2022 | n/a | -$66.1M | -$6.10 | n/a |
| 2021 | n/a | -$53.2M | -$6.88 | n/a |
| 2020 | n/a | -$35.2M | -$13.18 | n/a |
Latest SEC filings
What Outlook Therapeutics, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 18, 2026Other event 8-K
- August 27, 2026
- August 19, 2026Passive stake (5% or more) SCHEDULE 13G
- August 18, 2026Quarterly report 10-Q · period to June 30, 2026
- August 17, 2026Late quarterly report notice NT 10-Q
- August 14, 2026Activist stake changed SCHEDULE 13D/A
- August 14, 2026Other event 8-K
- August 14, 2026
- August 14, 2026
- August 12, 2026
Questions about OTLK
What does Outlook Therapeutics, Inc. do?
Outlook Therapeutics, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker OTLK.
Is Outlook Therapeutics, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $61.1M.
When did Outlook Therapeutics, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 18, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the other event from September 18, 2026.
Similar companies
Follow OTLK
Get an email when Outlook Therapeutics, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow OTLK: get an email when it filesWhere the numbers come from
Financial figures are the values Outlook Therapeutics, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.